Neuromedin B receptor antagonists which demonstrate selectivity
US5462926A · kind A · utility
8Cited by
1References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 17, 1993 |
| Grant date | Oct 31, 1995 |
| Priority date | — |
| Expiry date | Jun 17, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/6555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of selectively inhibiting biochemical activity of cells induced by neuromedin B. The method includes the step of contacting cells which contain neuromedin B receptor with a cyclic octapeptide, D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH.sub.2, or an analog thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.